SEARCH

SEARCH BY CITATION

References

  • 1
    National Institute for Health & Clinical Excellence. Intramural urethral bulking procedures for stress urinary incontinence in women. Interventional Procedures Guidance 138. London: NICE, 2005 [http://www.nice.org.uk/nicemedia/pdf/ip/IPG138guidance.pdf]. Accessed 22 March 2009.
  • 2
    Sweat SD, Lightner DJ. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 1999;161:936.
  • 3
    Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 2006;175:140810.
  • 4
    Hagemeier T, Blau U, Gauruder-Burmester A, Tunn R. Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence—management of complications and retrospective comparison with bladder neck located injection technique [German]. Zentralbl Gynakol 2006;128:6870.
  • 5
    Coull N, Dover K, Walker RMH. Sterile abscess formation following periurethral injections for stress urinary incontinence—an underestimated complication. Br J Med Surg Urol 2008;1:1424.
  • 6
    Morton HC, Hilton P. Urethral injury in association with mid-urethral tape procedures used in the treatment of stress urinary incontinence. BJOG 2009;116:11206.
  • 7
    Elzayat EA, Karsenty G, Bismar TA, Corcos J. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:24752.